
TY  - JOUR
TI  - 2012 Annual Meeting Works in Progress Poster Session Abstracts
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 72
IS  - S16
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.23770
DO  - doi:10.1002/ana.23770
SP  - S121
EP  - S132
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 48
IS  - 8
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2000.tb06881.x
DO  - doi:10.1111/j.1532-5415.2000.tb06881.x
SP  - S12
EP  - S135
PY  - 2000
ER  - 

TY  - JOUR
TI  - Abstracts of the 6th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 10-13 May 2011
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 224
IS  - S2
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.2957
DO  - doi:10.1002/path.2957
SP  - S1
EP  - S39
PY  - 2011
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
VL  - 41
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2011.02508.x
DO  - doi:10.1111/j.1365-2362.2011.02508.x
SP  - 23
EP  - 86
PY  - 2011
ER  - 

TY  - JOUR
TI  - Scientific Abstracts
JO  - Pediatric Transplantation
VL  - 13
IS  - s1
SN  - 1397-3142
UR  - https://doi.org/10.1111/j.1399-3046.2009.01146.x
DO  - doi:10.1111/j.1399-3046.2009.01146.x
SP  - 46
EP  - 156
PY  - 2009
ER  - 

TY  - JOUR
AU  - Kawecki, Fabien
AU  - Clafshenkel, William P.
AU  - Fortin, Michel
AU  - Auger, François A.
AU  - Fradette, Julie
C7  - 1700919
TI  - Biomimetic Tissue-Engineered Bone Substitutes for Maxillofacial and Craniofacial Repair: The Potential of Cell Sheet Technologies
JO  - Advanced Healthcare Materials
JA  - Adv. Healthcare Mater.
VL  - 7
IS  - 6
SN  - 2192-2640
UR  - https://doi.org/10.1002/adhm.201700919
DO  - doi:10.1002/adhm.201700919
SP  - 1700919
KW  - bone substitutes
KW  - cell sheet
KW  - prevascularization
KW  - stem cells
KW  - tissue engineering
PY  - 2018
AB  - Abstract Maxillofacial defects are complex lesions stemming from various etiologies: accidental, congenital, pathological, or surgical. A bone graft may be required when the normal regenerative capacity of the bone is exceeded or insufficient. Surgeons have many options available for bone grafting including the ?gold standard? autologous bone graft. However, this approach is not without drawbacks such as the morbidity associated with harvesting bone from a donor site, pain, infection, or a poor quantity and quality of bone in some patient populations. This review discusses the various bone graft substitutes used for maxillofacial and craniofacial repair: allografts, xenografts, synthetic biomaterials, and tissue-engineered substitutes. A brief overview of bone tissue engineering evolution including the use of mesenchymal stem cells is exposed, highlighting the first clinical applications of adipose-derived stem/stromal cells in craniofacial reconstruction. The importance of prevascularization strategies for bone tissue engineering is also discussed, with an emphasis on recent work describing substitutes produced using cell sheet-based technologies, including the use of thermo-responsive plates and the self-assembly approach of tissue engineering. Indeed, considering their entirely cell-based design, these natural bone-like substitutes have the potential to closely mimic the osteogenicity, osteoconductivity, osteoinduction, and osseointegration properties of autogenous bone for maxillofacial and craniofacial reconstruction.
ER  - 

TY  - JOUR
AU  - Yazawa, Masahiko
AU  - Cseprekal, Orsolya
AU  - Helmick, Ryan A.
AU  - Talwar, Manish
AU  - Balaraman, Vasanthi
AU  - Podila, Pradeep S. B.
AU  - Agbim, Uchenna A.
AU  - Maliakkal, Benedict
AU  - Fossey, Sallyanne
AU  - Satapathy, Sanjaya K.
AU  - Sumida, Keiichi
AU  - Kovesdy, Csaba P.
AU  - Nair, Satheesh
AU  - Eason, James D.
AU  - Molnar, Miklos Z.
TI  - Association between post-transplant donor-specific antibodies and recipient outcomes in simultaneous liver–kidney transplant recipients: single-center, cohort study
JO  - Transplant International
JA  - Transpl Int
VL  - 33
IS  - 2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13543
DO  - doi:10.1111/tri.13543
SP  - 202
EP  - 215
KW  - C1q binding donor-specific antibodies
KW  - de novo donor-specific antibodies
KW  - donor-specific antibodies
KW  - simultaneous liver–kidney transplantation
PY  - 2020
AB  - Summary There is a dearth of published data regarding the presence of post-transplant donor-specific antibodies (DSA), especially C1q-binding DSA (C1q+DSA), and patient and kidney allograft outcomes in simultaneous liver?kidney transplant (SLKT) recipients. We conducted a retrospective cohort study consisted of 85 consecutive SLKT patients between 2009 and 2018 in our center. Associations between presence of post-transplant DSA, including persistent and/or newly developed DSA and C1q+DSA, and all-cause mortality and the composite outcome of mortality, allograft kidney loss, and antibody-mediated rejection were examined using unadjusted and age and sex-adjusted Cox proportional hazards and time-dependent regression models. The mean age at SLKT was 56 years and 60% of the patients were male. Twelve patients (14%) had post-transplant DSA and seven patients (8%) had C1q+DSA. The presence of post-transplant DSA was significantly associated with increased risk of mortality (unadjusted model: Hazard Ratio (HR) = 2.72, 95% confidence interval (CI): 1.06?6.98 and adjusted model: HR = 3.20, 95% CI: 1.11?9.22) and the composite outcome (unadjusted model: HR = 3.18, 95% CI: 1.31?7.68 and adjusted model: HR = 3.93, 95% CI: 1.39?11.10). There was also higher risk for outcomes in recipients with C1q+DSA compared the ones without C1q+DSA. Post-transplant DSA is significantly associated with worse patient and kidney allograft outcomes in SLKT. Further prospective and large cohort studies are warranted to better assess these associations.
ER  - 

TY  - JOUR
AU  - Garzon, Maria C.
AU  - Kahn, Teri A.
AU  - Siegfried, Elaine C.
AU  - Silverman, Robert A.
AU  - Paller, Amy S.
TI  - Proceedings of the Society for Pediatric Dermatology Meeting, June 29—July 1, 1995, Vancouver, British Columbia, Canada
JO  - Pediatric Dermatology
VL  - 12
IS  - 4
SN  - 0736-8046
UR  - https://doi.org/10.1111/j.1525-1470.1995.tb00207.x
DO  - doi:10.1111/j.1525-1470.1995.tb00207.x
SP  - 376
EP  - 385
PY  - 1995
ER  - 

TY  - JOUR
TI  - Posters Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 3
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12229
DO  - doi:10.1002/rth2.12229
SP  - 1
EP  - 891
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 18
IS  - 2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.1994.tb00037.x
DO  - doi:10.1111/j.1530-0277.1994.tb00037.x
SP  - 420
EP  - 525
PY  - 1994
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12250
DO  - doi:10.1111/all.12250
SP  - 189
EP  - 336
PY  - 2013
ER  - 

TY  - JOUR
TI  - ACTS Abstracts
JO  - Clinical and Translational Science
JA  - Clinical And Translational Science
VL  - 8
IS  - 3
SN  - 1752-8054
UR  - https://doi.org/10.1111/cts.12290
DO  - doi:10.1111/cts.12290
SP  - 178
EP  - 258
PY  - 2015
ER  - 

AU  - de Berker, D.A.R
AU  - Baran, R.
AU  - Dawber, R.P.R.
C7  - pp. 172-222
TI  - The Nail in Dermatological Diseases
SN  - 9780632053582
UR  - https://doi.org/10.1002/9780470694947.ch5
DO  - doi:10.1002/9780470694947.ch5
SP  - 172-222
KW  - biochemical analysis
KW  - pityriasis rosea
KW  - keratosis lichenoides chronica
KW  - eczema
KW  - psoriatic arthritis
PY  - 2015
AB  - Summary This chapter contains section titled: Psoriasis Pityriasis Rubra Pilaris Eczema Pityriasis Rosea Parakeratosis Pustulosa (Hjorth-Sabouraud) Lichen Planus Lichen Striatus Lichen Nitidus Lichen Aureus Keratosis Lichenoides Chronica Discoid Lupus Erythematosus Bullous Pemphigoid Pemphigus Alopecia Areata Darier's Disease Porokeratosis of Mibelli Stevens-Johnson Syndrome (Erythema Multiforme Toxic Epidermal Necrolysis Acroosteolysis Acrokeratoelastoidosis Pityriasis Lichenoides Acuta Punctate Keratoderma Granuloma Annulare Erythema Elevatum Diutinum
ER  - 

TY  - JOUR
TI  - 11TH BIENNIAL MEETING OF THE ASIA PACIFIC SOCIETY FOR SEXUAL MEDICINE  OCTOBER 6-10, 2007, JEJU, KOREA
JO  - The Journal of Sexual Medicine
VL  - 5
IS  - s5
SN  - 9780632053582
UR  - https://doi.org/10.1111/j.1743-6109.2008.001095.x
DO  - doi:10.1111/j.1743-6109.2008.001095.x
SP  - 197
EP  - 258
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 122
IS  - S2
SN  - 9780632053582
UR  - https://doi.org/10.1111/bcpt.12968
DO  - doi:10.1111/bcpt.12968
SP  - 3
EP  - 67
PY  - 2018
ER  - 

TY  - JOUR
TI  - GLIA Edinburgh 2017: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 65
IS  - S1
SN  - 9780632053582
UR  - https://doi.org/10.1002/glia.23157
DO  - doi:10.1002/glia.23157
SP  - E103
EP  - E578
PY  - 2017
ER  - 

TY  - JOUR
TI  - Concurrent Oral Sessions: All Organs
JO  - American Journal of Transplantation
VL  - 14
IS  - S3
SN  - 9780632053582
UR  - https://doi.org/10.1111/ajt.12876
DO  - doi:10.1111/ajt.12876
SP  - 7
EP  - 15
PY  - 2014
ER  - 

TY  - JOUR
TI  - POSTERS: Epilepsy
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 70
IS  - S15
SN  - 9780632053582
UR  - https://doi.org/10.1002/ana.22560
DO  - doi:10.1002/ana.22560
SP  - S153
EP  - S162
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts of the Joint Conference of the Canadian Society for Transfusion Medicine, Canadian Blood Services and Héma-Québec, Banff, Alberta, Canada, 21–24 April 2005
JO  - Transfusion Medicine
VL  - 15
IS  - 4
SN  - 9780632053582
UR  - https://doi.org/10.1111/j.0958-7578.2005.00597.x
DO  - doi:10.1111/j.0958-7578.2005.00597.x
SP  - 337
EP  - 367
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 173
IS  - S1
SN  - 9780632053582
UR  - https://doi.org/10.1111/bjh.14019
DO  - doi:10.1111/bjh.14019
SP  - 5
EP  - 178
PY  - 2016
ER  - 
